Medhealth insight

Scientists discover novel antibodies that might enhance flu vaccines

Share post:

Flu, for many, might mean a week of feeling lousy, but for certain groups like seniors, kids, pregnant folks, and those with health conditions, it can be seriously risky. The CDC suggests flu shots, especially for these groups, as low vaccination rates concern health officials. Every year, the flu bug changes its game, so vaccines switch gears to match what’s expected for the upcoming flu season. But these flu types are tricky—they’ve got different strains and some play nicer with vaccines than others.

Researchers at the University of Pittsburgh might’ve cracked the code. They discovered special antibodies that could take on multiple flu strains. This finding, published in PLOS Biology, hints at a future vaccine that could cover a wide range of flu strains.

Dr. Kevin McCarthy, from the University of Pittsburgh, explains how these antibodies are superheroes against the flu. They block various flu strains at once, something flu vaccines can’t always do since the flu is a master at dodging our immune system’s punches. McCarthy says these antibodies suggest that making better vaccines might not be as tough as we thought. The key might be skipping some common vaccine-making methods that can mess with our immune system’s target practice.

This study zoomed in on a change in certain flu strains that affect a protein called hemagglutinin. Think of it as the first step in the flu’s viral invasion. These antibodies found a way to beat those modified flu strains at their own game. What’s even more exciting? Some people can make antibodies that fight off various flu strains. With this knowledge, scientists can develop vaccines that are better at handling different flu types.

Dr. David Cutler from Providence Saint John’s Health Center in California sees this discovery as a game-changer in reducing the flu’s impact. But while this news is a ray of hope, it doesn’t mean the flu will vanish anytime soon.

Flu vaccines aren’t perfect—best case scenario, they’re around 50% effective. And having antibodies doesn’t guarantee you won’t catch the flu. There’s still a lot to uncover about our immune system and why some folks get sick despite vaccination. So, the flu might not disappear just yet, but this research is a step toward better, more effective vaccines that could mean fewer sick days and fewer hospital visits.

spot_img

Related articles

Patients View GenAI Differently for Mental...

A study conducted at Queensland University of Technology in...

Isarna Therapeutics Announces Positive Final Results...

Isarna Therapeutics has announced positive data from its international...

Atossa Therapeutics Secures New Patent for...

Atossa Therapeutics, Inc. (NASDAQ: ATOS), a clinical-stage biopharmaceutical company,...

KNUST Students Innovate Smart Syringe Pump...

Otema Darfour Manu and Bright Mensah have developed an...